A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
A classification for medications uses to treat rare medical conditions. This status offers financial incentives to drug manufactures who may not see significant return on researching these drugs. In many countries, it is a matter of public policy to develop orphan drugs.
See also:
Drug usage/utilisation review (DUR)
New Drug Application (NDA)
Off-label use
Open-label trial
Over the counter (OTC)
Research and development (R&D)
Institutional review board (IRB) - pharmacoeconomics, Inclusion/exclusion criteria, Open-label trial, Pharmaceutical Researchers and Manufacturers of America (PhRMA), Blind (clinical trial terms), Product pipeline, Committee for Medicinal Products for Human Use (CHMP), Interventions - clinical, Peer review, Intent to treat, Prevention trials, Meta analysis, Placebo-controlled trial, Generic medicine, Arm,
MadMicrobe is an award-winning team of certified medical illustrators creating animations that engage your audience with immersive experiences that bring...